Your browser doesn't support javascript.
loading
mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model.
Cacicedo, Maximiliano L; Weinl-Tenbruck, Christine; Frank, Daniel; Wirsching, Sebastian; Straub, Beate K; Hauke, Jana; Okun, Jürgen G; Horscroft, Nigel; Hennermann, Julia B; Zepp, Fred; Chevessier-Tünnesen, Frédéric; Gehring, Stephan.
Afiliación
  • Cacicedo ML; Children's Hospital, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Weinl-Tenbruck C; CureVac AG, Friedrich-Miescher-Str. 15, 72076 Tübingen, Germany.
  • Frank D; Children's Hospital, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Wirsching S; Children's Hospital, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Straub BK; Institute of Pathology, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Hauke J; Division of Child Neurology and Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Okun JG; Division of Child Neurology and Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Horscroft N; MRM Health, Technologiepark, 739052 Zwijnaarde, Belgium.
  • Hennermann JB; Children's Hospital, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Zepp F; Children's Hospital, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Chevessier-Tünnesen F; CureVac AG, Friedrich-Miescher-Str. 15, 72076 Tübingen, Germany.
  • Gehring S; Children's Hospital, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
Mol Ther Methods Clin Dev ; 26: 294-308, 2022 Sep 08.
Article en En | MEDLINE | ID: mdl-35949297

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2022 Tipo del documento: Article País de afiliación: Alemania